[go: up one dir, main page]

WO1992010514A3 - Antigenes synthetiques pour la detection d'anticorps diriges contre le virus de l'hepatite c - Google Patents

Antigenes synthetiques pour la detection d'anticorps diriges contre le virus de l'hepatite c Download PDF

Info

Publication number
WO1992010514A3
WO1992010514A3 PCT/EP1991/002409 EP9102409W WO9210514A3 WO 1992010514 A3 WO1992010514 A3 WO 1992010514A3 EP 9102409 W EP9102409 W EP 9102409W WO 9210514 A3 WO9210514 A3 WO 9210514A3
Authority
WO
WIPO (PCT)
Prior art keywords
detection
antibodies
hcv
hepatitis
virus
Prior art date
Application number
PCT/EP1991/002409
Other languages
English (en)
Other versions
WO1992010514A2 (fr
Inventor
Robert J Deleys
Dirk Pollet
Geert Maertens
Heuverswijn Hugo Van
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26125651&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1992010514(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Priority to CA2074370A priority Critical patent/CA2074370C/fr
Priority to BR919106220A priority patent/BR9106220A/pt
Priority to KR1019970708500A priority patent/KR0181344B1/ko
Priority to KR1019970708501A priority patent/KR0181345B1/ko
Priority to KR1019920701932A priority patent/KR0181343B1/ko
Priority to AU90689/91A priority patent/AU652013B2/en
Publication of WO1992010514A2 publication Critical patent/WO1992010514A2/fr
Publication of WO1992010514A3 publication Critical patent/WO1992010514A3/fr
Priority to US08/466,975 priority patent/US5910404A/en
Priority to US10/044,995 priority patent/US6872520B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Séquences peptidiques capables d'imiter les protéines codées par le virus de l'hépatite C (HCV) et de servir de réactifs pour dépister une exposition préalable au HCV dans le sang et les produits sanguins. Les peptides ont une longueur d'au moins 5 acides aminés et peut s'utiliser dans divers dosages spécifiques destinés à détecter les anticorps dirigés contre le HCV, ou les antigènes du HCV, ou peuvent servir d'immunogènes.
PCT/EP1991/002409 1990-12-14 1991-12-13 Antigenes synthetiques pour la detection d'anticorps diriges contre le virus de l'hepatite c WO1992010514A2 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CA2074370A CA2074370C (fr) 1990-12-14 1991-12-13 Antigenes synthetiques pour le depistage d'anticorps du virus de l'hepatite c
BR919106220A BR9106220A (pt) 1990-12-14 1991-12-13 Antigenos sinteticos para a deterccao de anticorpos para o virus da hepatite c.
KR1019970708500A KR0181344B1 (ko) 1990-12-14 1991-12-13 간염 씨이 바이러스에 대한 항체 검출용 합성 항원
KR1019970708501A KR0181345B1 (ko) 1990-12-14 1991-12-13 간염 씨 바이러스에 대한 항체 검출용 합성 항원
KR1019920701932A KR0181343B1 (ko) 1990-12-14 1991-12-13 간염 씨 바이러스에 대한 항체 검출용 합성 항원
AU90689/91A AU652013B2 (en) 1990-12-14 1991-12-13 Synthetic antigens for the detection of antibodies to hepatitis C virus
US08/466,975 US5910404A (en) 1990-12-14 1995-06-06 Synthetic antigens for the detection of antibodies to hepatitis C virus
US10/044,995 US6872520B2 (en) 1990-12-14 2002-01-15 Synthetic antigens for the detection of antibodies to hepatitis C virus

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG1996005024A SG47062A1 (en) 1990-12-14 1990-12-14 Synthetic antigens for the detection of antibodies to hepatitis virus
EP90124241A EP0489968B1 (fr) 1990-12-14 1990-12-14 Antigènes synthétiques pour la détection des anticorps contre le virus de l'hépatite C
EP90124241.2 1990-12-14

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US07920286 A-371-Of-International 1991-12-31
US92028692A Continuation 1990-12-14 1992-10-14
US08/391,671 Continuation US5922532A (en) 1990-12-14 1995-02-21 Synthetic antigens for the detection of antibodies to hepatitis C virus

Publications (2)

Publication Number Publication Date
WO1992010514A2 WO1992010514A2 (fr) 1992-06-25
WO1992010514A3 true WO1992010514A3 (fr) 1992-08-20

Family

ID=26125651

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1991/002409 WO1992010514A2 (fr) 1990-12-14 1991-12-13 Antigenes synthetiques pour la detection d'anticorps diriges contre le virus de l'hepatite c

Country Status (18)

Country Link
US (1) US5922532A (fr)
EP (3) EP0489968B1 (fr)
JP (1) JP2995216B2 (fr)
KR (3) KR0181345B1 (fr)
AT (3) ATE144993T1 (fr)
AU (1) AU652013B2 (fr)
BR (1) BR9106220A (fr)
CY (2) CY2043A (fr)
DE (2) DE69030124T2 (fr)
DK (3) DK0754704T3 (fr)
ES (3) ES2138784T3 (fr)
GR (3) GR3022089T3 (fr)
HK (1) HK57597A (fr)
HU (1) HU218357B (fr)
IL (1) IL100158A (fr)
NZ (1) NZ240964A (fr)
SG (1) SG47062A1 (fr)
WO (1) WO1992010514A2 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US5712087A (en) * 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
EP0770679B2 (fr) * 1990-11-03 2009-12-30 Siemens Healthcare Diagnostics Products GmbH Peptides spécifiques pour HCV, préparations les contenant et leur utilisation
US5910404A (en) * 1990-12-14 1999-06-08 Innogenetics N.V. Synthetic antigens for the detection of antibodies to hepatitis C virus
EP0571554A1 (fr) * 1991-01-14 1993-12-01 James N. Gamble Institute Of Medical Research Polypeptides immunogeniques structuraux de base ayant des epitopes pour vhc, anticorps, sequences de polynucleotides, vaccins et methodes
JP3516681B2 (ja) 1991-06-24 2004-04-05 カイロン コーポレイション Ｃ型肝炎ウイルス（ｈｃｖ）ポリペプチド
DE4209215A1 (de) 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
US5811246A (en) * 1991-12-17 1998-09-22 The Research Foundation Of State University Of New York Process for immobilization onto the surfaces of ELISA plates of a compound carrier complex and for immunization
ZA928954B (en) * 1991-12-24 1993-05-19 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-A, non-B virus.
JP3443809B2 (ja) 1992-03-06 2003-09-08 エヌ・ブイ・インノジェネティクス・ソシエテ・アノニム 免疫学的に重要なエピトープに相当するペプチドの決定方法、及び免疫学的に重要なエピトープに相当するビオチニル化ペプチド又は抗体の決定のための方法におけるその利用、その調製方法及びそれを含む組成物
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
DE69334323D1 (de) * 1992-07-16 2010-05-06 Advanced Life Science Inst Inc Antigenetische Peptide für die Gruppierung des Hepatitis C Virus sowie Reagenzien und Verfahren dafür
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
FI946066L (fi) 1993-04-27 1994-12-23 Innogenetics Nv Hepatiitti-C viruksen genotyyppien uudet sekvenssit ja niiden käyttö terapeuttisina ja diagnostisina aineina
IT1270941B (it) * 1993-05-12 1997-05-26 Sorin Biomedica Spa Peptidi di hcv e loro usi.
US7070790B1 (en) * 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
EP0829488A4 (fr) * 1995-04-28 1999-04-07 Srl Inc Compose peptidique antigenique et methode de dosage immunologique
FR2775690B1 (fr) * 1998-03-09 2001-12-14 Bio Merieux Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc
WO1999058561A1 (fr) * 1998-05-14 1999-11-18 Pasteur Merieux Serums & Vaccins Mimotopes du virus de l'hepatite c
US7052830B1 (en) * 1998-06-09 2006-05-30 Branch Andrea D Hepatitis C virus peptides and uses thereof
ATE303597T1 (de) * 2000-07-07 2005-09-15 Medmira Inc Hcv mosaik antigen zusammensetzung
AUPQ899400A0 (en) * 2000-07-26 2000-08-17 Csl Limited A method of stabilisation and compositions for use therein
EP1978365B1 (fr) 2007-03-16 2010-08-25 Sysmex Corporation Kit de réactif et procédé de mesure d'anti-corps HCV
JP4975601B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
JP4975600B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
ES2303496B1 (es) * 2008-02-21 2009-07-07 Fundacion Para El Estudio De Las Hepatitis Virales Metodo analitico perfeccionado para la deteccion de hepatitis c oculta, aplicaciones del mismo y su correspondiente kit de diagnostico.
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
FR2987836A1 (fr) * 2012-03-09 2013-09-13 Biomerieux Sa Peptides d'interference et procede de detection de microorganismes
CN114858907B (zh) * 2021-02-04 2025-02-18 北京毅新博创生物科技有限公司 用于诊断新冠病毒感染的质谱模型的构建方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0388232A1 (fr) * 1989-03-17 1990-09-19 Chiron Corporation Diagnostics et vaccins de NANBV

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US594854A (en) * 1897-12-07 Territory
US505611A (en) * 1893-09-26 Henry v
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4749259A (en) * 1987-05-15 1988-06-07 Hughes Aircraft Company Liquid crystal image projection with multicolor prepolarizing system
CA1341629C (fr) * 1987-11-18 2012-05-08 Chiron Corporation Diagnostic de l'hepatite c, ainsi que des vaccins contre cette maladie
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
AU638304B2 (en) * 1989-12-22 1993-06-24 Abbott Laboratories Hepatitis c assay
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
EP0445801A3 (en) * 1990-03-08 1992-07-01 Kuraray Co., Ltd. Peptide and its use
ZA912040B (en) * 1990-03-30 1991-12-24 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus
WO1991015771A1 (fr) * 1990-04-04 1991-10-17 Chiron Corporation Combinaisons d'antigenes du virus de l'hepatite c (vhc) utilisees dans des immunoanalyses visant a detecter la presence d'anticorps anti-vhc
DE69132332T2 (de) * 1990-04-06 2000-11-30 Genelabs Technologies, Inc. Hepatitis c-virus-epitope
AU635124B2 (en) * 1990-04-16 1993-03-11 United Biomedical Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
WO1992001714A1 (fr) * 1990-07-24 1992-02-06 Yamanouchi Pharmaceutical Co., Ltd. Antigene du virus de l'hepatite non a, non b
CA2047792C (fr) * 1990-07-26 2002-07-02 Chang Y. Wang Peptides synthetiques specifiques pour la detection des anticorps diriges contre le vhc, diagnostic de l'infection a vhc et sa prevention grace a des vaccins
JP3114731B2 (ja) * 1990-08-14 2000-12-04 国立感染症研究所長 Ｃ型肝炎ウイルス抗体検出用ペプチド抗原及びその使用方法
CA2090335A1 (fr) * 1990-08-25 1992-02-26 Suzanne Zebedee Antigene du virus de l'hepatite non a, non b, methodes diagnostiques et vaccins
JP2949822B2 (ja) * 1990-10-03 1999-09-20 住友化学工業株式会社 熱可塑性樹脂組成物
EP0770679B2 (fr) * 1990-11-03 2009-12-30 Siemens Healthcare Diagnostics Products GmbH Peptides spécifiques pour HCV, préparations les contenant et leur utilisation
CA2055149A1 (fr) * 1990-11-08 1992-05-09 Hiroaki Okamoto Antigene, anticorps, systemes de detection, polynucleotides et polypeptides lies au virus de l'hepatite non a, non b
EP0516859A1 (fr) * 1990-11-29 1992-12-09 Toray Industries, Inc. Proteine anti-genique du virus de l'hepatite non a et non b
DK0501557T3 (da) * 1991-03-01 1995-04-10 Akzo Nobel Nv Peptider, der er immunokemisk reaktive med antistoffer rettet mod hepatitis non-A, non-B-virus
FI923448L (fi) * 1991-08-02 1993-02-03 Akzo Nv Non-a, non-b-peptid
ZA927243B (en) * 1991-10-07 1994-01-26 Akzo Nv Non-A, Non-B peptides
JP3443809B2 (ja) * 1992-03-06 2003-09-08 エヌ・ブイ・インノジェネティクス・ソシエテ・アノニム 免疫学的に重要なエピトープに相当するペプチドの決定方法、及び免疫学的に重要なエピトープに相当するビオチニル化ペプチド又は抗体の決定のための方法におけるその利用、その調製方法及びそれを含む組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0388232A1 (fr) * 1989-03-17 1990-09-19 Chiron Corporation Diagnostics et vaccins de NANBV

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Jap. J. Exp. Med., vol. 60, no. 4, 1990, H. OKAMOTO et al.: "Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide", pages 223-233, see summary *
Peptide Chemistry, 1990, Proceedings of the 28th Symposium on Peptide Chemistry, Osaka, 25-27 October 1990, E. MUNEKATA et al.: "Epitope-mapping of hepatitis C virus constituting protein", pages 211-214, see the entire document *

Also Published As

Publication number Publication date
AU9068991A (en) 1992-07-08
GR3022089T3 (en) 1997-03-31
DK0489968T3 (da) 1997-03-24
GR3023664T3 (en) 1997-09-30
DK0644202T3 (da) 1997-09-15
EP0754704B1 (fr) 1999-10-06
KR0181343B1 (ko) 1999-04-01
DE69029092D1 (de) 1996-12-12
GR3032150T3 (en) 2000-04-27
ATE149522T1 (de) 1997-03-15
HU218357B (hu) 2000-08-28
CY2043A (en) 1998-02-20
ES2138784T3 (es) 2000-01-16
JP2995216B2 (ja) 1999-12-27
HU9202645D0 (en) 1993-01-28
DE69030124D1 (de) 1997-04-10
DK0754704T3 (da) 2000-04-03
SG47062A1 (en) 1998-03-20
EP0754704A3 (fr) 1997-05-28
BR9106220A (pt) 1993-03-30
KR0181344B1 (ko) 1999-04-01
AU652013B2 (en) 1994-08-11
IL100158A (en) 1998-02-22
KR0181345B1 (ko) 1999-04-01
EP0489968A1 (fr) 1992-06-17
CY2053B1 (en) 1998-04-30
ATE144993T1 (de) 1996-11-15
ATE185350T1 (de) 1999-10-15
WO1992010514A2 (fr) 1992-06-25
EP0644202B1 (fr) 1997-03-05
DE69030124T2 (de) 1997-09-18
HUT65930A (en) 1994-07-28
KR920703632A (ko) 1992-12-18
JPH05503722A (ja) 1993-06-17
EP0754704A2 (fr) 1997-01-22
DE69029092T2 (de) 1997-04-17
EP0489968B1 (fr) 1996-11-06
EP0644202A1 (fr) 1995-03-22
NZ240964A (en) 1992-10-28
HK57597A (en) 1997-05-09
US5922532A (en) 1999-07-13
ES2095852T3 (es) 1997-03-01
ES2101388T3 (es) 1997-07-01

Similar Documents

Publication Publication Date Title
WO1992010514A3 (fr) Antigenes synthetiques pour la detection d'anticorps diriges contre le virus de l'hepatite c
HUT73098A (en) Hepatitis c virus (hcv) polypeptides
RU94024561A (ru) Иммунореактивные композиции, способ получения композиции, способы получения и обнаружения антител, набор днк, клетка-хозяин, способ получения белка
IL101425A0 (en) Peptides and mixtures thereof for detecting antibodies to hepatitis c virus,methods for their use and pharmaceutical compositions containing the same
DE3887750D1 (de) Selektive entfernung von immunkomplexen.
SG95574A1 (en) Immunoreactive antigens of hepatitia e virus
EP1878797A3 (fr) Peptides antigéniques pour le groupage du virus de l'hépatite C, kit comprenant ceux-ci et procédé de groupage les utilisant
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus
ATE134648T1 (de) Künstliche polypeptide und antikörper in zusammenhang mit epstein-barr-virus-nuklear- antigen
AP9300556A0 (en) Peptides,analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
FI952778L (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA HU JP KR US

WWE Wipo information: entry into national phase

Ref document number: 2074370

Country of ref document: CA

AK Designated states

Kind code of ref document: A3

Designated state(s): AU BR CA HU JP KR US